Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSGeneric

JYNNEOS

Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen

Standard Dose
Refer to label-specific dosage instructions.
Max Dose
See product label
Primary Use
Marketed injection, powder, lyophilized, for suspension containing VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN.
Summary

Product profile Marketed injection, powder, lyophilized, for suspension containing VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN.

Dose form and route INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · SUBCUTANEOUS

Structured Monograph

Clinical summary

Product profile Marketed injection, powder, lyophilized, for suspension containing VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN. Dose form and route INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · SUBCUTANEOUS

Monitoring

  • • Review the product-specific label before prescribing.

Interaction Notes

  • • Interaction data should be confirmed against the corresponding label.
JYNNEOS (Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen) | Drug Monograph | MedicHelpline